Franklin Clyburn

Franklin Clyburn

Director/Board Member at REVOLUTION MEDICINES, INC.

Net worth: 919 179 $ as of 31/05/2026

61 year
Health Technology
Consumer Services
Commercial Services

Profile

Franklin K.
Clyburn
is currently Director at the European Federation of Pharmaceutical Industries & Assns, Director at Kailera Therapeutics, Inc. starting in 2025, Independent Director at Revolution Medicines, Inc. starting in 2024, and Independent Director at Cencora, Inc. starting in 2024.
Former positions include Chief Executive Officer & Executive Director at International Flavors & Fragrances, Inc. from 2022 to 2024, Chairman-Trustees Board at Thomas Edison State University from 2013 to 2019, Director at A Better Chance, Inc., Independent Director at DuPont de Nemours, Inc. from 2019 to 2022, Executive VP & President-Human Health at Merck & Co., Inc. from 2021 to 2022, Chief Commercial Officer & Executive VP at Merck Research Laboratories Massachusetts LLC from 2019 to 2021, and VP-Oncology & Internal Medicine Business Units at Sanofi-Aventis, Inc. from 2004 to 2008.
Education includes an MBA from Arizona State University and undergraduate studies at Franklin & Marshall College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
05/03/2026 1,724 ( 0% ) 464 377 $ 31/05/2026
31/03/2026 2,888 ( 0% ) 454 802 $ 31/05/2026

Franklin Clyburn active positions

CompaniesPositionStart
REVOLUTION MEDICINES, INC. Director/Board Member 05/08/2024
CENCORA, INC. Director/Board Member 01/10/2024
Director/Board Member -

Former positions of Franklin Clyburn

CompaniesPositionEnd
INTERNATIONAL FLAVORS & FRAGRANCES INC. Chief Executive Officer 06/02/2024
MERCK & CO., INC. Corporate Officer/Principal 01/02/2022
DUPONT DE NEMOURS, INC. Director/Board Member 20/01/2022
Corporate Officer/Principal 01/01/2021
Chairman 01/01/2019
See the detail of Franklin Clyburn's experience

Training of Franklin Clyburn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

74

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Consumer Non-Durables

Health Technology

Distribution Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Process Industries

Health Technology

Consumer Services

  1. Stock Market
  2. Insiders
  3. Franklin Clyburn
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!